Verona Pharma plc (VRP.L) (LON:VRP – Get Free Report) shares passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 55 ($0.74) and traded as high as GBX 56 ($0.75). Verona Pharma plc (VRP.L) shares last traded at GBX 55 ($0.74), with a volume of 70,791 shares traded.
Verona Pharma plc (VRP.L) Stock Up 5.8 %
The company has a quick ratio of 2.47, a current ratio of 2.99 and a debt-to-equity ratio of 6.85. The company has a 50 day simple moving average of GBX 55 and a two-hundred day simple moving average of GBX 55. The company has a market capitalization of £228.00 million and a P/E ratio of -1.68.
About Verona Pharma plc (VRP.L)
Verona Pharma plc, a clinical stage biopharmaceutical company, develops and commercializes therapeutics to treat respiratory diseases. The company's product candidate is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which has completed Phase I and II clinical trials that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, chronic asthma, and allergic rhinitis.
Read More
- Five stocks we like better than Verona Pharma plc (VRP.L)
- Dividend Payout Ratio Calculator
- Simon Property REIT: A Safe Bet for Growth and Steady Dividends
- Technology Stocks Explained: Here’s What to Know About Tech
- CarMax’s Impressive Rally: What Investors Should Watch Next
- Investing in the High PE Growth Stocks
- MarketBeat Week in Review – 9/23 – 9/27
Receive News & Ratings for Verona Pharma plc (VRP.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma plc (VRP.L) and related companies with MarketBeat.com's FREE daily email newsletter.